• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Celgene Corporation

Celgene Corporation

  1. All
  2. Morningstar Articles
  3. 3rd Party
  4. Investing
  1. Global Mitogen-Activated Protein Kinase 8 Pipeline Report 2016 - Celgene Corporation , Eisai Co., Ltd. & OPKO Health, Inc. - Research and Markets

    Global Mitogen-Activated Protein Kinase 8 Pipeline Report 2016 - Celgene Corporation , Eisai Co., Ltd. & OPKO Health, Inc. - Research and Markets

  2. UPDATE: Bull trend intact, latest S&P 500 -2-

    UPDATE: Bull trend intact, latest S&P 500 -2-

  3. UPDATE: Bull trend intact, latest S&P 500 breakout attempt underway

    UPDATE: Bull trend intact, latest S&P 500 breakout attempt underway

  4. Bull trend intact, latest S&P 500 breakout -2-

    Bull trend intact, latest S&P 500 breakout -2-

  5. Bull trend intact, latest S&P 500 breakout attempt underway

    Bull trend intact, latest S&P 500 breakout attempt underway

  6. T-Cell Immunotherapy for Cancer - Pipeline Analysis 2016 - Research and Markets

    T-Cell Immunotherapy for Cancer - Pipeline Analysis 2016 - Research and Markets

  7. UPDATE: This beaten-down biotech stock is a cure for your portfolio

    UPDATE: This beaten-down biotech stock is a cure for your portfolio

  8. UPDATE: This beaten-down biotech stock is a cure for your portfolio

    UPDATE: This beaten-down biotech stock is a cure for your portfolio

  9. UPDATE: This beaten-down biotech stock is a cure for your portfolio

    UPDATE: This beaten-down biotech stock is a cure for your portfolio

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.